Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
- 26 May 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 141 (21) , 1665-1666
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?The Lancet Respiratory Medicine, 2020
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic targetIntensive Care Medicine, 2020
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)Physiological Reviews, 2018
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005